期刊文献+

Et-DHA通过激活线粒体途径和T细胞granzymeB诱导HepG2细胞凋亡 被引量:2

Et-DHA induces apoptosis of HepG2 cells through activation of mitochondrial pathway and induction of granzyme B expression in T cells
在线阅读 下载PDF
导出
摘要 目的:本研究探讨了二十二碳六烯酸乙酯(Et-DHA)对人肝癌HepG2细胞凋亡的影响。方法:HepG2细胞用于检测Et-DHA的抑癌活性,MTT法检测Et-DHA对HepG2细胞的直接抑制作用,Hoechst 33258荧光染色观察细胞的形态特征,ELISA法检测Et-DHA处理后HepG2细胞的活性氧簇(ROS)释放量、总超氧化物歧化酶(SOD)和caspase-9活性,Western blotting法检测胞质和线粒体中Bax、Bak、Bid、Bcl-2、Smac和细胞色素C(Cyt C),以及胞质中cleaved caspase-8、cleaved caspase-9和cleaved caspase-3的水平;T细胞与HepG2细胞共培养,进一步观察Et-DHA处理后T细胞的增殖对HepG2细胞活性的影响,并检测了颗粒酶(granzyme)B的水平。结果:Et-DHA显著抑制HepG2细胞的生长(P<0.05),这种抑制作用具浓度效应和时程效应;Et-DHA处理后HepG2细胞的ROS释放量增加,但总SOD活性无明显变化,caspase-9活性显著上升(P<0.05);线粒体上的促凋亡蛋白Bax、Bak和Bid水平增加,而抑凋亡蛋白Bcl-2以及线粒体中Cyt C和Smac的水平降低,胞质中的Cyt C、Smac、cleaved caspase-8、cleaved caspase-9、cleaved caspase-3以及cleaved Bid水平呈剂量性升高。另外T细胞和HepG2细胞共培养组在Et-DHA的诱导下,HepG2细胞的凋亡程度与Et-DHA单独作用时相比进一步增加。在Et-DHA刺激下,T细胞内granzyme B上调,释放到HepG2细胞内的granzyme B明显增多。结论:Et-DHA可能主要通过线粒体内源性途径以及caspase-8途径,激活caspase-3,诱导HepG2细胞凋亡,以及通过间接活化T细胞,促使granzyme B增多,从而增强对HepG2细胞的毒性作用。 AIM: To investigate the effect of ethyl docosahexaenoate (Et-DHA) on the apoptosis of human hepatocarcin0ma HepG2 cells. METHODS : HepG2 cells were used to test the anticarcinogenicity of Et-DHA. The direct inhibition of HepG2 cells by Et-DHA was detected by MrIT. Nuclear morphological features of the HepG2 ceils were ob served under fluorescence microscope after staining with Hochest 33258. The levels of Bax, Bak, Bid, Bcl-2, Smac and cytochrome C (Cyt C) in mitochondria and cytosol, the cleaved caspase-8, cleaved caspase-9, and cleaved caspase-3 in cytosol, as well as the release of reactive oxygen species ( ROS), total superoxide dismutase (SOD) and caspase-9 activity in the Et-DHA-treated HepG2 cells were determined by Western blotting and ELISA. Furthermore, by co-culturing the HepG2 cells with T ceils, the effects of proliferation of Et-DHA-treated T cells on the activity of HepG2 cells were ob served, and the level of granzyme B was detected. RESULTS : Et-DHA significantly inhibited the growth of HepG2 cells ina concentration and time-dependent manner. The ROS release and caspase-9 activity increased markedly in Et-DHA-trea- ted HepG2 cells, and no significant change of the total SOD activity was observed. The levels of the pro-apoptotic proteins Bax, Bak and Bid in mitochondria increased, the anti-apoptotic protein Bcl-2 as well as mitochondrial Cyt C and Smac lev els decreased, and the cytoplasmic Cyt C, Smac, cleaved caspase-$, cleaved caspase-9, cleaved caspase-3 and cleaved Bid levels showed dose-dependent increases. Additionally, the degree of Et-DHA-induced apoptosis in HepG2 cells in the co-culture group ( T cells + HepG2 cells) showed a further increase as compared with the HepG2 cells treated with Et-DHA alone. Due to Et-DHA inducing elevation of granzyme B level in the T cells, the granzyme B released into HepG2 cells was significantly increased. CONCLUSION : Et-DHA might induce the apoptosis of HepG2 cells through activation of caspase 3 mainly via a mitochondrial intrinsic pathway and a caspase-8 pathway, and promote the increase in granzyme B indirectly by activating T cells, thus enhancing the cytotoxic effect on HepG2 cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第3期385-393,共9页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.31171281) 广州市教育局科技计划项目(No.10A044)
关键词 二十二碳六烯酸 HEPG2细胞 半胱氨酸天冬氨酸蛋白酶9 颗粒酶B 细胞色素C SMAC蛋白 Dbcosahexaenoic acids HepG2 cells Caspase-9 Granzyme B Cytochrome C Smac protein
  • 相关文献

参考文献3

二级参考文献20

  • 1Ling-fei WU,Guo-ping LI,Jia-lin FENG,Ze-jin PU.Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells[J].Acta Pharmacologica Sinica,2006,27(4):477-484. 被引量:7
  • 2Llovet JM,Burroughs A,Bruix J.Hepatocellular carcino-ma[J].Lancet,2003,362(9399):1907-1917.
  • 3Yoo HY,Patt CH,Geschwind JF,et al.The outcome of liver transplantation in patients with hepatocellular carcino-ma in the United States between1988and2001:5-year survival has improved significantly with time[J].J Clin Oncol,2003,21(23):4329-4335.
  • 4Allgaier HP,Deibert P,Olschewski M,et al.Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection-a single-center a-nalysis including132patients[J].Int J Cancer,1998,79(6):601–605.
  • 5Takayasu K,Wakao F,Moriyama N,et al.Postresection recurrence of hepatocellular carcinoma treated by arterial embolization:analysis of prognostic factors[J]Hepatolo-gy,1992,16(4):906-911.
  • 6Farag SS,VanDeusen JB,Fehniger TA,et al.Biology and clinical impact of human natural killer cells[J].Int J Hematol,2003,78(1):7-17.
  • 7Wada Y,Nakashima O,Kutami R,et al.Clinicopatho-logical study on hepatocellular carcinoma with lymphocytic infiltration[J].Hepatology,1998,27(2):407-414.
  • 8Cai L,Zhang Z,Zhou L,et al.Functional impairment in circulating and intrahepatic NK cells and relative mecha-nism in hepatocellular carcinoma patients[J].Clin Immu-nol,2008,129(3):428-437.
  • 9Korangy F,Hchst B,Manns MP,et al.Immune respon-ses in hepatocellular carcinoma[J].Dig Dis,2010,28(1):150-154.
  • 10Miyagi T,Takehara T,Tatsumi T,et al.CD1d-media-ted stimulation of natural killer T cells selectively activates hepatic naturalkiller cells to eliminate experimentally dis-seminated hepatoma cells in murine liver[J].Int J Canc-er,2003,106(1):81-89.

共引文献21

同被引文献40

  • 1王聚乐,李长山,顿珠,周惠英.藏药结血蒿水提物的免疫抑制作用研究[J].四川大学学报(医学版),2006,37(6):908-912. 被引量:13
  • 2施国海,周佩军,王祥慧,徐达,施敏敏,陈皓.FTY720对体外混合培养淋巴细胞增殖和凋亡的影响[J].上海交通大学学报(医学版),2007,27(4):380-383. 被引量:6
  • 3Yang JW,Han ST,Kim YS,et al.Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity.Transplant Proc,2010;42(10):4625-4632.
  • 4Bossini N,Sandrini S,Casari S,et al.Kidney transplantation in HIV-positive patients treated with a steroid-free immunosuppressive regimen.Transpl Int,2014Jun 25.doi:10 .1111/tri.12377.[Epub ahead of print].
  • 5Matz M,Weber U,Mashreghi M.Effects of the new immunosuppressive agent AEB071on human immune cells.Nephrol Dial Transplant,2010;25(7):226-230.
  • 6Li HQ,Luo Y,Song R,et al.Design,synthesis,and immunosuppressive activity of new deoxybenzoin derivatives.Chem Med Chem,2010;5(7):1117-1122.
  • 7Yano H,Thakur A,Tomaszewski EN.Ipilimumab augments antitumor activity of bispecific antibody-armed T cells.J Transl Med,2014;12(1):191-192.
  • 8Ward MD,Jones DE,Goldman MD.Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.Expert Opin Drug Saf,2014;13(7):989-998.
  • 9Aoudjehane L,Podevin P,Conti F.Interleukin-4induces human hepatocyte apoptosis through a Fas-independent pathway.FASEB J,2007;21(7):1433-1444.
  • 10Ntranos A,Hall O,Robinson DP.FTY720impairs CD8T-cell function independently of the sphingosine-1-phosphate pathway.J Neuroimmunol,2014;270(1-2):13-21.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部